Viewing Gene With Clinical Trials Data

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Report Bug Request Feature
Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol: CCR2
Name: C-C motif chemokine receptor 2
Location: 03p21.31
Locus Group: protein-coding gene
Gene Type: Protein Coding
Locus Type: gene with protein product
ID+ Clinical Trials CompTox DrugMatrix Conditions Design Enrollment Locations Outcomes
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all

Clinical Studies

NCT Number Status Brief Title View
NCT01340222 Monocyte Chemotactic Protein-1 MCP-1 Expressing Monocytes to Predict Preterm Delivery PhenoMAP Study View
NCT04916704 Subclinical Cytomegalovirus Reactivation in Acute ANCA-associated Vasculitis View
NCT03373552 Genetic Polymorphism Associated With Coronary Heart Disease Susceptibility and Variability of Clopidogrel Response View
NCT05202548 Immunology Dysregulation in Lymphadenitis Tuberculosis An Observational Study Using Patient Block Paraffins 2019 Until 2021 View
NCT04500418 Charité Trial of Cenicriviroc CVC Treatment for COVID-19 Patients View
NCT00689273 Randomized Double-Blind Placebo-Controlled Phase 2 Study In Subjects With Osteoarthritic Pain Of The Knee View
NCT00699790 Proof of Confidence Study of CCR2 Antagonist BMS-741672 in Insulin Resistance View
NCT01015560 S0916 MLN1202 in Treating Patients With Bone Metastases View
NCT01098877 First In Human Study Of Increasing Oral Doses Of PF-04634817 View
NCT02330549 ORION Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or Type 2 Diabetes Mellitus T2DM and Suspected NAFLD View
NCT01765946 Metformin and Longevity Genes in Prediabetes View
NCT05183646 A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB View
NCT03492762 PET Imaging CCR2 in Lung Inflammation View
NCT02388971 Proof of Mechanism Study of MLN1202 on Atherosclerotic Inflammation in Participants With Stable Atherosclerotic Cardiovascular Disease View
NCT03778879 Pre-operative Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma With or Without CCX872-B View
NCT03851237 CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy View
NCT02817568 Frequency Of MCP-1 And CCR2 Gene Polymorphisms And Its Effect On Gene Expression In Patients With AgP View
NCT06275893 IC14 Atibuclimab in Arrhythmogenic Cardiomyopathy View
NCT04206033 Hemophilia and Bone Metabolism Study of Monocytic Populations and Inflammatory Proteins View
NCT04217057 Imaging CCR2 Receptors With 64Cu-DOTA-ECL1i in Head and Neck Cancer View
NCT04537403 PET Detection of CCR2 in Human Atherosclerosis View
NCT04586452 NIH CCR2 AAA Study View
NCT04592991 CCR2 AAA Pilot Study View
NCT05107596 Evaluation of CCR2 in Patients Post Myocardial Infarction View
NCT05122182 Controlled Trial of Angiotensin Receptor Blocker ARB Chemokine Receptor Type 2 CCR2 Antagonist for the Treatment of COVID-19 View